Publications by authors named "William H Walker Ii"

Aging is a risk factor for the development of breast cancer. Foundational science studies have supported associations among neuroinflammation, breast cancer, and chemotherapy, but to date, these associations are based on studies using young adult rodents. The current study examined the neuroinflammatory effects of chemotherapy in aged, tumor-naïve and tumor-bearing mice with or without social enrichment.

View Article and Find Full Text PDF
Article Synopsis
  • The study explored how immune responses, metabolism, and sleep are interconnected in mice with non-metastatic mammary cancer, focusing on the role of interleukin-6 (IL-6) and its effects.
  • Tumor-bearing mice exhibited increased hunger, decreased leptin levels, and heightened sensitivity to ghrelin, with inflammation from IL-6 present but not entirely responsible for metabolic and sleep issues.
  • By investigating specific brain neurons linked to metabolism and sleep, researchers found that blocking certain receptors improved metabolic health and sleep quality, highlighting the significance of neural signals in cancer-related metabolic changes.
View Article and Find Full Text PDF

Breast cancer survivors are more likely to develop mood disorders and cognitive deficits than women in the general population. Previous studies suggest that peripheral tumors elicit central pro-inflammatory cytokine production, in turn leading to depression and cognitive deficits. In the current study, two cohorts of female Balb/C mice received bilateral orthotopic injections of syngeneic 67NR, 4T07, or 4T1cells (1 × 10 cells per injection) to induce mammary tumors.

View Article and Find Full Text PDF

Many cytotoxic chemotherapeutics elicit a proinflammatory response which is often associated with chemotherapy-induced behavioral alterations. The immune system is under circadian influence; time-of-day may alter inflammatory responses to chemotherapeutics. We tested this hypothesis by administering cyclophosphamide and doxorubicin (Cyclo/Dox), a common treatment for breast cancer, to female BALB/c mice near the beginning of the light or dark phase.

View Article and Find Full Text PDF